Kolexia
Vulquin Noemie Oncologie radiothérapie
Vulquin Noemie
Oncologie radiothérapie
Centre Georges-François Leclerc
Dijon, France
44 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la tête et du cou Carcinomes Carcinome épidermoïde Récidive tumorale locale Carcinome épidermoïde de la tête et du cou Tumeurs de l'oesophage Tumeurs du poumon Métastase tumorale Carcinome pulmonaire à petites cellules

Collaborateurs

Voir plus
Maingon Philippe
Maingon Philippe
Hôpital Pitie Salpetriere, Paris, France
Crehange Gilles
Crehange Gilles
Clcc Institut Curie, Paris, France
Truc Gilles
Truc Gilles
Centre Georges-François Leclerc, Dijon, France
Quivrin Magali
Quivrin Magali
Centre Georges-François Leclerc, Dijon, France

Industries

Voir plus
Merck-Serono
1 collaboration(s)
Dernière en 2017
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION): A Randomized, Double-blind, Placebo-controlled, 2-arm Phase III Study to Assess Efficacy and Safety of Xevinapant and Radiotherapy Compared to Placebo and Radiotherapy for Demonstrating Improvement of Disease-free Survival in Participants With Resected Squamous Cell Carcinoma of the Head and Neck, Who Are at High Risk for Relapse and Are Ineligible for High-dose Cisplatin (XRAY VISION)
Essai Clinique (Emd Serono)   05 mars 2024
A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer.
BMC cancer   09 novembre 2023
IMMUNOs-SBRT: An Open-label, Multi-centric, Phase I, Evaluating the Safety and the Efficacy of Combination of Atezolizumab, Tiragolumab and and Stereotactic Body Radiation Therapy in Patients With Oligometastatic Multiorgan (IMMUNOs-SBRT)
Essai Clinique (Centre Georges-François Leclerc)   16 octobre 2023
PembroMetaRT: Randomized Trial of Loco-regional Radiotherapy Added to Pembrolizumab Alone or With Chemotherapy Versus Systemic Treatment Alone for Patients With Newly Diagnosed Head and Neck Squamous Cell Carcinoma With Synchronous Metastases
Essai Clinique (Unicancer)   12 octobre 2023
Management of 80 sinonasal undifferentiated carcinomas. Retrospective multicentre study of the French Network of Rare Head and Neck Cancers (REFCOR).
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology   05 octobre 2023
Predictive value of health-related quality of life on radiotherapy-related toxicities in patients with head and neck cancer.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer   14 avril 2023
Predictive Value of Health-Related Quality of Life on Radiotherapy Related Toxicities in Patients with Head and Neck Cancer
International journal of radiation oncology, biology, physics   01 avril 2022
ETOILE: Transnational Randomized Study Comparing Carbon Ions Therapy Versus Conventional Radiotherapy - Including Protontherapy - for the Treatment of Radioresistant Tumors
Essai Clinique (Hospices Civils de Lyon)   01 septembre 2021
Randomized Trial Assessing the Impact of Routine Assessment of Health-Related Quality of Life in Patients with Head and Neck Cancer.
Cancers   29 juillet 2021
Histosurgical mapping of endoscopic endonasal surgery of sinonasal tumours to improve radiotherapy guidance.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   24 juin 2021